EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identifying squalene epoxidase as a metabolic vulnerability in high‐risk osteosarcoma using an artificial intelligence‐derived prognostic index

Yongjie Wang iD, Xiaolong Ma, Enjie Xu, Zhen Huang, Chen Yang, Kunpeng Zhu iD, Yang Dong iD, Chunlin Zhang iD

Clinical and Translational Medicine · 2024

DOI: 10.1002/ctm2.1586 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2024. Verfasst von Yongjie Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, P. R. China. Hauptthemen laut MEDLINE: Bone Neoplasms, Osteosarcoma, Squalene Monooxygenase. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Climbing Talents Program of Shanghai Tenth People's Hospital, Clinical Research Program of Shanghai Tenth People's Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Osteosarcoma (OSA) presents a clinical challenge and has a low 5‐year survival rate. Currently, the lack of advanced stratification models makes personalized therapy difficult. This study aims to identify novel biomarkers to stratify high‐risk OSA patients and guide treatment.

Methods

We combined 10 machine‐learning algorithms into 101 combinations, from which the optimal model was established for predicting overall survival based on transcriptomic profiles for 254 samples. Alterations in transcriptomic, genomic and epigenomic landscapes were assessed to elucidate mechanisms driving poor prognosis. Single‐cell RNA sequencing (scRNA‐seq) unveiled genes overexpressed in OSA cells as potential therapeutic targets, one of which was validated via tissue staining, knockdown and pharmacological inhibition. We characterized changes in multiple phenotypes, including proliferation, colony formation, migration, invasion, apoptosis, chemosensitivity and in vivo tumourigenicity. RNA‐seq and Western blotting elucidated the impact of squalene epoxidase ( SQLE ) suppression on signalling pathways.

Results

The artificial intelligence‐derived prognostic index (AIDPI), generated by our model, was an independent prognostic biomarker, outperforming clinicopathological factors and previously published signatures. Incorporating the AIDPI with clinical factors into a nomogram improved predictive accuracy. For user convenience, both the model and nomogram are accessible online. Patients in the high‐AIDPI group exhibited chemoresistance, coupled with overexpression of MYC and SQLE , increased mTORC1 signalling, disrupted PI3K–Akt signalling, and diminished immune infiltration. ScRNA‐seq revealed high expression of MYC and SQLE in OSA cells. Elevated SQLE expression correlated with chemoresistance and worse outcomes in OSA patients. Therapeutically, silencing SQLE suppressed OSA malignancy and enhanced chemosensitivity, mediated by cholesterol depletion and suppression of the FAK/PI3K/Akt/mTOR pathway. Furthermore, the SQLE‐specific inhibitor FR194738 demonstrated anti‐OSA effects in vivo and exhibited synergistic effects with chemotherapeutic agents.

Conclusions

AIDPI is a robust biomarker for identifying the high‐risk subset of OSA patients. The SQLE protein emerges as a metabolic vulnerability in these patients, providing a target with translational potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone NeoplasmsOsteosarcomaSqualene MonooxygenaseHumansArtificial IntelligenceBiomarkersPhosphatidylinositol 3-KinasesPrognosisProto-Oncogene Proteins c-akt

Stichwörter der Autor:innen

machine learningosteosarcomaprognostic modelsqualene epoxidase

Substanzen

BiomarkersPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSqualene MonooxygenaseSQLE protein, human

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, P. R. China.
  • Institute of Bone Tumor Affiliated to Tongji University School of Medicine, Shanghai, P. R. China.
  • Proteomics and Cancer Cell Signaling Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
  • Department of Orthopaedics, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai, P. R. China.

ORCID-Profile: Yongjie Wang, Kunpeng Zhu, Yang Dong, Chunlin Zhang

Förderung

  • National Natural Science Foundation of China
  • Climbing Talents Program of Shanghai Tenth People's Hospital
  • Clinical Research Program of Shanghai Tenth People's Hospital
  • Program for Research-oriented Physician of Shanghai Tenth People's Hospital

Zitieren

APA

Wang, Y., Ma, X., Xu, E., Huang, Z., Yang, C., Zhu, K., Dong, Y., & Zhang, C. (2024). Identifying squalene epoxidase as a metabolic vulnerability in high‐risk osteosarcoma using an artificial intelligence‐derived prognostic index. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1586

Vancouver

Wang Y, Ma X, Xu E, Huang Z, Yang C, Zhu K, et al. Identifying squalene epoxidase as a metabolic vulnerability in high‐risk osteosarcoma using an artificial intelligence‐derived prognostic index. Clinical and Translational Medicine. 2024. doi:10.1002/ctm2.1586

BibTeX
@article{Wang2024,
  author = {Wang, Yongjie and Ma, Xiaolong and Xu, Enjie and Huang, Zhen and Yang, Chen and Zhu, Kunpeng and Dong, Yang and Zhang, Chunlin},
  title = {Identifying squalene epoxidase as a metabolic vulnerability in high‐risk osteosarcoma using an artificial intelligence‐derived prognostic index},
  journal = {Clinical and Translational Medicine},
  year = {2024},
  doi = {10.1002/ctm2.1586}
}
Kostenlos starten →